Due to health issues, this site is no longer maintained and will be shut down shortly.

CF:LXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp. focuses on the development of its proprietary nutrient infusion technologies for the production of superfoods. It operates in two segments, Intellectual Property Licensing and Consumer Products. The company develops and licenses DehydraTECH, a patented lipid nutrient infusion technology that improves taste, rapidity, and delivery of bioactive compounds that include cannabinoids, vitamins, non-steroidal anti-inflammatory drugs, nicotine, and other molecules. It is also involved in the development, production, and distribution of enhanced functional food and supplement products under the ViPova, TurboCBD, ChrgD+ and Lexaria Energy brands. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol LEXX.

This company has cross-listed shares that trade in the U.S. as the symbol LEXX.

8.40 CAD
As of 07/08/2021

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Unknown
Industry:  Packaged Foods
Index country:  Canada
Country of incorporation:  
IPO date:  01/01/1900
Stock exchange:    Canadian Securities Excha
Exchange country:   Canada
Market cap:   42,876,372 CAD
Current dividend yield:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy